FDA outlines 2027 AI guidance plans; nurses can comment on generative AI framework until October 19
The FDA has set out its AI guidance plans for 2027 and developed a regulatory blueprint for generative AI-enabled devices. The deadline for comments on the draft is October 19.
Who is affected and how
- medtech company
- Developers of generative AI devices need to follow the FDA framework, as it will shape future authorisation expectations.
- health policy
- The FDA's 2027 plans point to the direction of future oversight of AI devices.
Sources
- FDA spells out 2027 AI guidance plansstat · Oct 6, 2026
- STAT Health Tech: FDA spells out 2027 AI guidance plansstatnews.com · Oct 6, 2026
- FDA puts final AI device lifecycle guidance at top of its 2027 priorities | World Health AIworldhealth.ai · Oct 7, 2026
- FDA Signals 2027 Timeline for New AI Health Tech Guidance | The Beat | The Beatthebeat.tech · Oct 7, 2026
- STAT+: FDA spells out 2027 AI guidance plans · Wortinswortins.com · Oct 7, 2026
- Nurses Have Until October 19 to Weigh In on the FDA’s Generative AI Device Frameworknurse.org · Oct 5, 2026
- FDA’s Generative AI Medical Device Discussion Paperpharmout.net · Oct 7, 2026
- FDA Develops Regulatory Blueprint for Generative AI-Enabled Devices | News | Haynes Boone - JDSuprajdsupra.com · Oct 5, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.